Dr. Lalanthica Vilashini Yogendran, MD, MPH

Dr. Yogendran practices at UC Medical Center in Cincinnati, Ohio.

Dr. Yogendran's NPI, 1225429574, was assigned on February 9, 2015. Dr. Yogendran holds Ohio license 35146022.

Dr. Yogendran's primary practice is UC Medical Center, at 3188 Bellevue Ave, Cincinnati, OH 45219 in Hamilton County. The practice phone is (513) 584-1000.

Dr. Yogendran's primary practice is UC Medical Center in Cincinnati, Ohio. Dr. Yogendran is also affiliated with University of Cincinnati Medical Center. The medical group on file is University of Cincinnati Physicians. Dmand AI also links Dr. Yogendran to 4 more hospitals, 1 group practice or clinic, 1 skilled nursing facility and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yogendran practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Yogendran's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Yogendran's licenses on file in 2 states: Ohio and Kentucky.

CMS data shows 401 Medicare services from Dr. Yogendran across 4 procedure codes in 2024, for 74 Medicare patients. Medicare paid $19,232 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 74 Medicare patients who saw Dr. Yogendran in 2024. The largest group is 65 to 74, with 40 patients. 66% of them have high blood pressure, and 61% have high cholesterol. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yogendran's median patient age at 56, with 53% women.

In 2024, Dr. Yogendran wrote 283 Medicare Part D claims for 52 patients. 89% of them were for generic drugs. CMS names the drug for 163 of them, across 8 drugs with 11 or more claims each, at $20,894 in total drug cost. In 2023, CMS named 100 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Yogendran for performance year 2024, reported through an alternative payment model (APM). Dr. Yogendran accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yogendran as offering telehealth.

Dmand AI links 7 papers to Dr. Yogendran, published from 2015 to 2024. 2022 was the busiest year, with 2. The most frequent topics are Brain Neoplasms and Glioblastoma. Dr. Yogendran's most frequent co-authors are Camilo E. Fadul, MD, Haroon Zafar Ahmad, MD and Ashok R. Asthagiri, MD.

CMS Open Payments shows 5 general payments to Dr. Yogendran from 5 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Novocure Inc. paid the most, $134.